Literature DB >> 6943028

The effect of liposome (phospholipid vesicle) entrapment of actinomycin D and methotrexate on the in vivo treatment of sensitive and resistant solid murine tumours.

S B Kaye, J A Boden, B E Ryman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6943028     DOI: 10.1016/0014-2964(81)90119-5

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  7 in total

1.  Incorporation of the antitumor alkaloid thaliblastine in liposomes enhances its cytotoxic activity in vitro.

Authors:  D K Todorov; G Deliconstantinos
Journal:  Experientia       Date:  1982-07-15

2.  Liposomes as drug carrier system for cis-diamminedichloroplatinum (II). II. Antitumor activity in vivo, induction of drug resistance, nephrotoxicity and Pt distribution.

Authors:  P A Steerenberg; G Storm; G de Groot; A Claessen; J J Bergers; M A Franken; Q G van Hoesel; K L Wubs; W H de Jong
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

Authors:  S Kim
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

4.  Antitumor effects of liposomal IL1 alpha and TNF alpha against the pulmonary metastases of the B16F10 murine melanoma in syngeneic mice.

Authors:  M Saito; D Fan; L B Lachman
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

5.  Increased therapeutic efficiency of a lipid-soluble alkylating agent incorporated in liposomes.

Authors:  J W Babbage; M C Berenbaum
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

6.  Superior therapeutic activity of liposome-associated adriamycin in a murine metastatic tumour model.

Authors:  A Gabizon; D Goren; Z Fuks; A Meshorer; Y Barenholz
Journal:  Br J Cancer       Date:  1985-05       Impact factor: 7.640

7.  Liposomally trapped AraCTP to overcome AraC resistance in a murine lymphoma in vitro.

Authors:  V J Richardson; G A Curt; B E Ryman
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.